VICTORIA, BC, May 22, 2024 /PRNewswire/ – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology…
The Innovative Brand Commemorates Significant Milestone with Memorial Day Exclusive Deal FORT LAUDERDALE, Fla., May 22, 2024 /PRNewswire-PRWeb/ — Today,…
MINNEAPOLIS, May 22, 2024 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics Inc., a biopharmaceutical company focused on the…